Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C13H21NO3.ClH |
| Molecular Weight | 275.772 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC=CC=C1OCC(O)CNC(C)C
InChI
InChIKey=JKEZSJIWQWVVQR-UHFFFAOYSA-N
InChI=1S/C13H21NO3.ClH/c1-10(2)14-8-11(15)9-17-13-7-5-4-6-12(13)16-3;/h4-7,10-11,14-15H,8-9H2,1-3H3;1H
| Molecular Formula | C13H21NO3 |
| Molecular Weight | 239.3107 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Moprolol is a beta-adrenergic antagonist, or beta blocker, typically prescribed to treat hypertension, high blood pressure, angina pectoris, arrhythmias, anxiety, and glaucoma. Moprolol has been the subject for many clinical trials to study the effect moprolol has on both blood pressure and glaucoma. In clinical trials, Moprolol shows some effect on lowering blood pressure with no effects on the heart rate. Moprolol is currently off the market, most likely due to the manufacturer being in violation of US good manufacturing practices.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6120901
75 mg
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:24:34 GMT 2025
by
admin
on
Mon Mar 31 22:24:34 GMT 2025
|
| Record UNII |
L42WT1PR63
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
248-195-3
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | |||
|
100000127441
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | |||
|
198065
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | |||
|
m1207
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB33487
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | |||
|
27058-84-0
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | |||
|
DTXSID50949814
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | |||
|
L42WT1PR63
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |